| Matthew S Devane, DO | |
|
106 La Casa Via, #140, Walnut Creek, CA 94598-3086 | |
| (925) 274-2860 | |
| (925) 932-4527 |
| Full Name | Matthew S Devane |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 31 Years |
| Location | 106 La Casa Via, Walnut Creek, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770511040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20A7765 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| John Muir Medical Center - Concord Campus | Concord, CA | Hospital |
| San Ramon Regional Medical Center | San ramon, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John Muir Physician Network | 6608789813 | 464 |
News Archive
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).
The emergency department is being increasingly utilized as a patient's best or only treatment option for opioid use disorder.
› Verified 7 days ago
| Entity Name | John Muir Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841407665 PECOS PAC ID: 6608789813 Enrollment ID: O20031226000143 |
News Archive
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).
The emergency department is being increasingly utilized as a patient's best or only treatment option for opioid use disorder.
› Verified 7 days ago
| Entity Name | University Healthcare Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760531198 PECOS PAC ID: 6305748799 Enrollment ID: O20040126000292 |
News Archive
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).
The emergency department is being increasingly utilized as a patient's best or only treatment option for opioid use disorder.
› Verified 7 days ago
| Entity Name | John Muir Trauma Physicians Billing Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093864837 PECOS PAC ID: 3476542515 Enrollment ID: O20050420001452 |
News Archive
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).
The emergency department is being increasingly utilized as a patient's best or only treatment option for opioid use disorder.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Devane, DO 106 La Casa Via, #140, Walnut Creek, CA 94598 Ph: (925) 274-2860 | Matthew S Devane, DO 106 La Casa Via, #140, Walnut Creek, CA 94598-3086 Ph: (925) 274-2860 |
News Archive
Moffitt Cancer Center researchers have found that breast and lung cancer patients who have low levels of a protein called tristetraprolin (TTP) have more aggressive tumors and a poorer prognosis than those with high levels of the protein.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).
The emergency department is being increasingly utilized as a patient's best or only treatment option for opioid use disorder.
› Verified 7 days ago
Dr. Joseph Patrick Henry, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396 | |
Mr. Ramin Khashayar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1399 Ygnacio Valley Rd, Ste 14, Walnut Creek, CA 94598 Phone: 925-939-3050 Fax: 925-939-3057 | |
Dr. Hennessey Tseng, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1450 Treat Blvd, Suite 220b, Walnut Creek, CA 94597 Phone: 925-937-1770 Fax: 925-937-0630 | |
Dr. Ali-reza Barmaki, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1220 Rossmoor Pkwy, Walnut Creek, CA 94595 Phone: 925-947-3393 Fax: 925-947-3396 | |
Dr. Cynthia M. Mullen, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2637 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-322-2372 Fax: 925-322-6720 | |
Mr. David Nathanson, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2000 | |
Mark D Nathan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 106 La Casa Via, #140, Walnut Creek, CA 94598 Phone: 925-274-2860 Fax: 925-932-4527 |